Skip to main content
Outset Medical, Inc. logo

Outset Medical, Inc. — Investor Relations & Filings

Ticker · OM ISIN · US6901451079 US Manufacturing
Open in API
Filings indexed 681 across all filing types
Latest filing 2026-01-27 Regulatory Filings
Country US United States of America
Listing US OM

About Outset Medical, Inc.

https://outsetmedical.com/

Outset Medical, Inc. is a medical technology company focused on transforming the dialysis experience for patients and healthcare providers. The company's primary product is the Tablo Hemodialysis System, an all-in-one device designed to reduce the cost and complexity of treatment. The system integrates water purification and on-demand dialysate production, enabling its use across the continuum of care, from hospital intensive care units to patients' homes. Designed for ease of use, Tablo facilitates rapid training for both clinicians and patients. It also features two-way wireless data transfer and cloud-based reporting to automate documentation and streamline treatment management, serving as a single enterprise solution for dialysis care.

Recent filings

Filing Released Lang Actions
8-K Filing
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 27, 2026. It announces a recent event: FDA clearance for a new product and plans for its launch. The content is an event announcement rather than a financial report or detailed analysis. It includes a press release as an exhibit but does not contain financial statements or detailed financial data. The Form 8-K is used for current event disclosures and does not fit into categories like Annual Report, Earnings Release, or Interim Report. It is a regulatory filing reporting a material event. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-01-27 English
4 Filing
Director's Dealing
2026-01-21 English
4 Filing
Director's Dealing
2026-01-21 English
4 Filing
Director's Dealing
2026-01-21 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-01-14 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Outset Medical, Inc. It includes announcements of a director resignation and appointment, as well as a preliminary unaudited financial results press release and an investor presentation. The document does not contain full financial statements or detailed financial analysis itself but references a forthcoming Annual Report on Form 10-K for the fiscal year ended December 31, 2025. The main substantive content is about management changes (director resignation and appointment) and a financial update press release. Therefore, the primary classification is Board/Management Information (MANG) due to the detailed disclosure of director changes. The financial results announcement is preliminary and furnished as an exhibit, not the full earnings release document itself. The investor presentation is also attached but secondary. Hence, the best fit is MANG with high confidence.
2026-01-12 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.